CPP News

Cancer Prevention Pharmaceuticals, which is developing treatments for colorectal cancer risk factors, withdrew its plans for an initial public offering on Wednesday. It originally set terms in February to raise $25 million, but later decreased the proposed offering size to $16 million ($99 million market cap). The company last updated its filing in May 2016. The Tucson,...read more

The year's most active week by deal count and proceeds is set to cap off the year's busiest month: The six scheduled IPOs would bring May's IPO count up to 16, making it the busiest month since...read more

Cancer Prevention Pharmaceuticals, which is developing treatments for colorectal cancer risk factors, lowered the proposed shares it plans to offer in its upcoming IPO. The deal's timing is day-to-day. The Tucson, AZ-based company now plans to raise $16 million by offering 1.25 million shares (down from 1.92 million) at the originally proposed price range of $12 to $14....read more

The IPO market is scheduled to have its busiest week yet. As many as six companies could go public this week and raise a combined $555 million, including the first venture capital-backed tech IPO of the year. Optical network IPO helps VC tech see the light ...read more